Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02347943 · ClinicalTrials.gov registry record
Global Sinus Surgery Registry
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- 252
- Enrollment target
NCT02347943 is a clinical trial that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 252 participants.
The verdict
NCT02347943 was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- 252 participants
- Enrollment target
Study Summary
This study evaluates long-term safety and effectiveness of primary sinus surgery in a real-world population of adults with chronic rhinosinusitis (CRS) or recurrent acute rhinosinusitis (RARS). This post-market study will evaluate sinus surgery performed using commercially available sinus instrumentation (e.g. sinus balloon catheters, powered microdebriders, manual instruments).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2015-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02347943
The ClinicalTrials.gov registry entry for NCT02347943 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02347943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02347943 about?
NCT02347943 is a clinical study titled "Global Sinus Surgery Registry". This study evaluates long-term safety and effectiveness of primary sinus surgery in a real-world population of adults with chronic rhinosinusitis (CRS) or recurrent acute rhinosinusitis (RARS). This post-market study will evaluate sinus surgery performed using commercially available sinus instrument...
What is the current status of trial NCT02347943?
This trial is currently terminated. The enrollment target is 252 participants. The study started on 2015-01-01. Estimated completion is 2015-11-01.
Who is sponsoring clinical trial NCT02347943?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.